Modifying effect of arterial hypertension on amyotrophic lateral sclerosis

References

• Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3.
   PubMed Web of Science ®Google Scholar
• Gallo V, Buenos de Mesquita HB, Vermeulen R, Andersen P, Kyrosis A, Linseisen J, . Smoking and risk for ALS: analysis of the EPIC cohort. Ann Neurol. 2009;65:378–85
   PubMed Web of Science ®Google Scholar
• Furby A, Beauvais K, Kolev I, Rivain JG, Sébille V. Rural environment and risk factors of ALS: a case-control study. J Neurol. 2010;257:792–8.
   PubMed Web of Science ®Google Scholar
• Piazza O, Siren AL, Ehrenreich H. Soccer, neurotrauma and ALS: is there a connection? Curr Med Res Opin. 2004;20: 505–8.
   PubMed Web of Science ®Google Scholar
• Chio A, Benzi G, Dossensa M, Mutani R , Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005;128:472–6.
   PubMed Web of Science ®Google Scholar
• Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain. 2001;124:2000–13.
   PubMed Web of Science ®Google Scholar
• Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, . Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet. 2001;28:131–8.
   PubMed Web of Science ®Google Scholar
• Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM, . VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature. 2004;429:413–7.
   PubMed Web of Science ®Google Scholar
• Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, . VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motor neurons against ischaemic death. Nat Genet. 2003;34: 383–94.
   PubMed Web of Science ®Google Scholar
• Terry PD, Kamel F, Umbach DM, Lehman TA, Hu H, Sandler DP, . VEGF promoter haplotype and amyotrophic lateral sclerosis (ALS). J Neurogenet. 2004;18:429–34.
   PubMed Web of Science ®Google Scholar
• Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, . ANG mutations segregate with familial and ‘sporadic’ amyotrophic lateral sclerosis. Nat Genet. 2006;38:411–3.
   PubMed Web of Science ®Google Scholar
• Devos D, Moreau C, Lassalle P, Perez T, de Seze J, Brunaud-Danel V, . Low levels of the vascular endothelial growth factor in CSF from early ALS patients. Neurology. 2004;62:2127–9.
   PubMed Web of Science ®Google Scholar
• Iłzecka J. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis. Clin Neurol Neurosurg. 2004;106:289–93.
   PubMed Web of Science ®Google Scholar
• Moreau C, Devos D, Brunaud-Danel V, Defebvre L, Perez T, Destée A, . Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS. J Neurol Neurosurg Psychiatry. 2006;77:255–7.
   PubMed Web of Science ®Google Scholar
• Moreau C, Gosset P, Brunaud-Danel V, Lassalle P, Degonne B, Destee A, . CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients. Amyotroph Lateral Scler. 2009;10:175–81.
   PubMed Web of Science ®Google Scholar
• Moreau C, Gosset P, Kluza J, Brunaud-Danel V, Lassalle P, Marchetti P, . Deregulation of the hypoxia inducible factor-1α pathway in monocytes from sporadic amyotrophic lateral sclerosis patients. Neuroscience. 2010;172:110–7.
   PubMedGoogle Scholar
• Hayashi T, Sakurai M, Abe K, Sadahiro M, Tabayashi K, Itoyama Y. Expression of angiogenic factors in rabbit spinal cord after transient ischaemia. Neuropathol Appl Neurobiol. 1999;25:63–71.
   PubMed Web of Science ®Google Scholar
• de la Torre JC, Stefano JB. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Research Reviews. 2000;34:119–36.
   PubMedGoogle Scholar
• Soriani MH, Desnuelle C. Epidemiology of ALS? Rev Neurol. 2009;165:627–40.
   PubMedGoogle Scholar
• Lang T, de Gaudemaris R, Chatellier G, Hamici L, Diene E. Prevalence and therapeutic control of hypertension in 30, 000 subjects in the workplace. Hypertension. 2001;38: 449–54.
   PubMed Web of Science ®Google Scholar
• Millecamps S, Salachas F, Cazeneuve C, Gordon P, Bricka B, Camuzat A, . SOD, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet. 2010;47:554–60.
   PubMed Web of Science ®Google Scholar
• Perez T. Amyotrophic lateral sclerosis (ALS): evaluation of respiratory function. Rev Neurol (Paris). 2006;162:S188–94.
   Google Scholar
• Fazekas F, Schmidt R, Offenbacher H, Niederkorn K, Horner S, Payer F, . Prevalence of white matter and peri-ventricular magnetic resonance hyperintensities in asymptomatic volunteers. J Neuroimaging. 1991;1:27–30.
   Google Scholar
• de Reuck J, Deramecourt V, Cordonnier C, Leys D, Maurage CA, Pasquier F. The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer's features: a neuropathological study. Eur J Neurol. 2011 (Epub ahead of print).
   PubMedGoogle Scholar
• Ferrières J, Bongard V, Dallongeville J, Arveiler D, Cottel D, Haas B, . Trends in plasma lipids, lipoproteins and dyslipidaemias in French adults, 1996–2007. Arch Cardiovasc Dis. 2009;102:293–301.
   PubMedGoogle Scholar
• Wagner A, Sadoun A, Dallongeville J, Ferrières J, Amouyel P, Ruidavets JB, . High blood pressure prevalence and control in a middle-aged French population and their associated factors: the MONA LISA study. J Hypertens. 2011;29: 43–50.
   PubMed Web of Science ®Google Scholar
• Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med. 1992;11:2093–109.
   PubMed Web of Science ®Google Scholar
• La Manna J, Chavez JC, Pichiule P. Structural and functional adaptation to hypoxia in the rat brain. The Journal of Experimental Biology. 2007;3163–9.
   Google Scholar
• Louwerse ES, Visser CE, Bossuyt PM, Weverling GJ. Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognosis factors. The Netherlands ALS Consortium. J Neurol Sci. 1997;152:S10–7.
   PubMed Web of Science ®Google Scholar
• Bourke SC, Shaw P, Gibson GJ. Respiratory function versus sleep disorders breathing as predictors of QoL in ALS. Neurology. 2001;57:2040–4.
   PubMed Web of Science ®Google Scholar
• Harding SM. Complications and consequences of obstructive sleep apnoea. Curr Opin Pulm Med. 2000;6:485–9.
   PubMedGoogle Scholar
• Sutedja NA, van der Schouw YT, Fischer K, Sizoo EM, Huisman MH, Veldink JH, . Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011 Apr 6. (Epub ahead of print).
   PubMedGoogle Scholar
• Norris F, Shepherd R, Denys E, Mukai E, Elias L, Holden D, . Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci. 1993; 118:48–55.
   PubMed Web of Science ®Google Scholar
• Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, . Early symptom progression rate is related to ALS outcome: a prospective population based study. Neurology. 2002;59:99–103.
   PubMed Web of Science ®Google Scholar
• del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population based study. Neurology. 2003;60:813–9.
   PubMed Web of Science ®Google Scholar
• Eisen A, Schulzer M, MacNeil M, Pant B, Mak E. Duration of ALS is age dependent. Muscle Nerve. 1993;16:27–32.
   PubMed Web of Science ®Google Scholar
• Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain. 1995;118:707–19.
   PubMed Web of Science ®Google Scholar
• Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, . Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66:265–7.
   PubMed Web of Science ®Google Scholar
• Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognosis factor for survival in ALS patients. Neurology. 1999;53:1059–63.
   PubMed Web of Science ®Google Scholar
• Arnulf I, Similowski T, Salachas F, Garma L, Mehiri S, Attali V, . Sleep disorders and diaphragmatic function in patients with amyotrophic lateral sclerosis. Am J Respir Crit Care Med. 2000;161:849–56.
   PubMed Web of Science ®Google Scholar
• Dupuis L, Corcia P, Fergani A, Gonzalez de Aguilar JL, Bonnefont-Rousselot D, Bitter R, . Dyslipidaemia is a protective factor in ALS. Neurology. 2008;70:1004–9.
   PubMed Web of Science ®Google Scholar